Loading clinical trials...
Loading clinical trials...
A Phase 1, Double-Blind (Sponsor Open), Randomized, Placebo-Controlled Trial To Evaluate The Effects Of 100 MG Once Daily Of Eplerenone On Serum Aldesterone And Plasma Renin Activity During 10 Days Of Dosing In Healthy Volunteers
Conditions
Interventions
Eplerenone or Placebo
Locations
2
United States
Pfizer Investigational Site
Miami, Florida, United States
Pfizer Investigational Site
South Miami, Florida, United States
Start Date
October 1, 2009
Primary Completion Date
November 1, 2009
Completion Date
November 1, 2009
Last Updated
December 22, 2020
NCT00104325
NCT07118891
NCT01399385
NCT03807401
NCT07499050
NCT05196061
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions